4. O BJECTIVES (10 Q UESTIONS ) Review and/or develop screening and immunization programs Provide counseling, follow-up, work restriction recommendations related to communicable disease or following exposures Assist with analysis and trending of occupational exposure incidents and information exchange between occupational health and infection prevention and control departments Assess risk for occupational exposure to infectious diseases (eg, TB, bloodborne pathogens)

5. E MPLOYEE /O CCUPATIONAL H EALTH P ROGRAMS

6. P ROGRAM O BJECTIVES (R ELATED TO I NFECTION P REVENTION ) Educate personnel Principles of IP and personnel’s role in prevention Collaborate with IP Monitor and investigate exposures and outbreaks Provide care to personnel Work-related illness or exposure Identify risk and institute preventive measures Work-related infection risks Contain costs by preventing infectious diseases Absenteeism and disability

7. O PERATIONS Screening Education and counseling Occupational illness and injury treatment Nonoccupational illness treatment Preventive health services Environmental assessment and control Record keeping

8. C OMMUNICATION WITH IP Personnel exposure Personnel infections Community and personnel outbreaks Policies and procedures Educational programs for personnel

9. H EALTHCARE P ERSONNEL “All paid and unpaid persons working in healthcare settings who have the potential for exposure to infectious materials, including body substances, contaminated medical supplies and equipment, contaminated environmental surfaces, or contaminated air.” http://www.cdc.gov/hicpac/pdf/InfectControl98.pdf

10. P OLICIES & P ROCEDURES Work restrictions Authority to remove personnel from duty Criteria for exposure and prophylaxis Screening procedures Illness reporting system Methods of detecting, preventing, & controlling disease Protocols for treatment Occupational injuries and illnesses Nonoccupational illness

11. E DUCATION New employee orientation & annual updates Postexposure counseling (Bloodborne Pathogens) TB screening and positive conversions Worker’s comp issues Pregnant worker concerns Community-acquired infections Influenza prevention MMR & Varicella protection and prevention Screening test results Guidelines for illness

12. A CTION P LAN : D ETECTION History of disease Symptoms Labs Reporting cases to health department

13. A CTION P LAN : P REVENTION & C ONTROL Isolation precautions for patients Work restrictions for personnel Prophylaxis of patients and personnel Educate patients and personnel Screening tests postexposure Follow up Secondary cases Delayed outbreak

14. S CREENING P ROGRAMS

15. D ECIDING TO SCREEN Disease in local population Risk of significant exposure Cost of screening Implication of the screening results

16. W HEN TO SCREEN Preemployment Medical history, immunization status Pregnancy, compromised immune status, infectious disease Periodical Changes in health status Illness during employment Outbreak/Exposure Evaluation of susceptibility Type and duration of exposure Prophylaxis

17. W HAT TO DO AT A SCREENING Medical history Health assessment Lab work TB screening Immunizations This information is confidential!

18. C OMMUNICABLE DISEASES TO SCREEN FOR Tuberculosis (TB) Rubella OB & Pediatrics  rubella, varicella, pertussis Blood/Body fluid exposures  hepatitis B

19. T UBERCULOSIS Includes essentially all healthcare personnel, even those entering patient or treatment rooms whether a patient is present or not. Full time, part time, PRN, contract TB testing protocols based on TB risk assessment Recent exposures and/or conversions Community population http://www.cdc.gov/tb/publications/guidelines/infectioncontrol.htm

20. TB S CREENING M ETHODS Purified protein derivative (PPD) skin testing Before employment and at intervals Two-step if no documented negative PPD within past year Interpret according to CDC guidelines QuantiFERON-TB (QFT) serum testing One-step, either + or - Chest radiograph Risk factors identified New positive reactors (repeat at intervals) History of symptoms Cough, weight loss, night sweats, etc

21. B LOODBORNE PATHOGENS exposure plan and immunization

22. OSHA R EGULATIONS Bloodborne Pathogen Act Develop an exposure plan Provide Hepatitis B vaccine within 10 days of employment Training on potential hazards, PPE, engineering controls and work practices (sharps safety) Must maintain sharps injury log https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=STANDARDS&p_id=10051

23. E XPOSURE PROCEDURES 1. Seek first aid (wash with soap & water, ER) 2. Notify immediate supervisor 3. Obtain baseline labs for HIV, Hepatitis B & C 4. Follow requirements for consent to obtain labs from source patient HIV, Hepatitis B & C 5. Document exposure ASAP per reporting methods 6. Follow up with occupational health for postexposure testing and counseling

24. P OSTEXPOSURE COUNSELING Risk of infection Signs and symptoms of infection Prophylaxis Testing Side effects of medications Interim precautions Risk reduction measures

25. R ESPIRATORY PROTECTION P ROGRAM

26. OSHA R EGULATIONS Program administrator required Fit test and seal check for respirator required for each worker Employer must provide respirators, training, and medical evaluations. https://www.osha.gov/SLTC/respiratoryprotection/index.html

27. F IT TEST Qualitative Pass/Fail Adequacy of fit Quantitative Adequacy of fit Measures amount of leakage Not required for PAPR (Powered air-purifying respirator)

28. W ORK R ESTRICTIONS active infections and post-exposure

29. W ORK RESTRICTIONS List which illnesses and conditions should be reported to occupational health in policies and procedures Communicate this to personnel and management Personnel who impose work restrictions should have their authority written in P&P Restriction should no penalize the personnel…or this will undermine reporting

30. D ECIDING WORK RESTRICTIONS Consider the following: Agent Mode of transmission Method of interruption of transmission Population at risk and susceptibility Educability and compliance of personnel Clinical status (signs & symptoms) Degree and type of patient and staff contact

31. Disease and symptom-specific guidance http://www.cdc.gov/hicpac/pdf/InfectControl98.pdf CDC R ECOMMENDATIONS

32. P OST - EXPOSURE

33. D ISEASES WITH NO POST - EXPOSURE TREATMENT Herpes simplex Cytomegalovirus Meningitis other than N. meningitidis RSV Rotavirus Hepatitis C (Controversial)

34. P OST - EXPOSURE : H EPATITIS C Refer to specialist treatment controversial, there is no guideline Exposure considered for HCV-positive source Baseline testing for anti-HCV and ALT May test in 4-6 weeks post-exposure for HCV RNA if desired Retest in 4-6 months post-exposure for anti-HCV and ALT

35. D ISEASES WITH POST - EXPOSURE INTERVENTION TB Evaluate and treat if symptomatic, no prophylaxis Measles Meningitis ( Neisseria meningitidis ) Hepatitis A, B Varicella-zoster (Chickenpox) Scabies Evaluate and treat if infested, no prophylaxis Pertussis HIV

36. P OST - EXPOSURE : TB Baseline skin testing Skin testing at 10 weeks after exposure Positive conversion (≥5mm, if baseline was 0mm)  Chest radiograph Laboratory tests (liver) Referral for medical evaluation No change  Consider retesting immunocompromised personnel every 6 months

37. P OST - EXPOSURE : M EASLES Check immunization status If immunity is in question, check titers Administer vaccine if susceptible within 72 hours of exposure Exclude from duty 5 days after first exposure to 21 days after last exposure

38. P OST - EXPOSURE : M ENINGITIS ( N EISSERIA MENINGITIDIS ) Exposure considered for personnel with potential direct droplet contact (mouth-to-mouth, assisting intubation, endotracheal suctioning) Prophylaxis immediately after exposure Ciprofloxacin oral (adults only, nonpregnant), Cefotaxime IM (children, pregnant), or Rifampin oral (children or adults)

39. P OST - EXPOSURE : H EPATITIS B Exposure considered if source is HbsAg positive or unknown Perform baseline anti-HBs only if exposed person is vaccinated, but titers have not been checked If unvaccinated, begin vaccine series at time of exposure and give HBIG (hepatitis B immune globulin) within 24 hours of exposure

40. P OST - EXPOSURE : HIV http://www.jstor.org/stable/pdfplus/10.1086/672271.pdf?acceptTC=true Immediately test personnel and source for HIV- AB status Baseline testing and follow up for 6 months 6 weeks, 3 months, and 6 months Postexposure prophylaxis (PEP) and counseling ASAP, if source is HIV-negative stop PEP Consult OB physician for pregnancy (not contraindicated but is complex)

41. I MMUNIZATIONS

42. V ACCINE PREVENTABLE DISEASES Hepatitis A and B Influenza Measles Mumps Rubella Tetanus and diphtheria Pertussis Polio Varicella-zoster (Chickenpox)

43. CDC R ECOMMENDATIONS http://www.cdc.gov/vaccines/adults/rec-vac/hcw.html

44. P ERFORMANCE I MPROVEMENT M EASURES